Biodegradable inflatable balloon for reducing radiation adverse effects in prostate cancer

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 91, Issue 2, 2009, Pages 855-867

  Levy, Yair ^a   Paz, Adrian ^b   Yosef, Rami Ben ^c   Corn, Benjamin W ^c   Vaisman, Boris ^a   Shuhat, Shaul ^b   Domb, Abraham J ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b Bioprotect Ltd   (Israel)

^c TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

Balloon barrier; Biodegradable implant; Prostate cancer; Radiation protection; Radiotherapy

Indexed keywords

ADVERSE EFFECT; BIODEGRADABLE IMPLANT; CAPROLACTONE; COATING METHODS; ERECTILE DYSFUNCTION; ETHYLENE OXIDES; IN-SITU; IN-VITRO; LACTIDES; MOUNTING DEVICE; NORMAL TISSUE; PHYSIOLOGICAL SALINE; PROSTATE CANCER; PROSTATE CANCERS; PROSTATE GLANDS; RADIATION INTENSITY; RADIATION THERAPY; SIDE EFFECT; URINARY FREQUENCY;

BALLOONS; BIODEGRADABLE POLYMERS; CHEMICAL PROPERTIES; ETHYLENE; MECHANICAL PROPERTIES; MECHANICAL STABILITY; RADIATION EFFECTS; RADIATION PROTECTION; RADIATION SHIELDING;

RADIOTHERAPY;

ETHYLENE OXIDE; POLY(LACTIDE CO EPSILON CAPROLACTONE).; POLYMER; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BALLOON; BIODEGRADABLE IMPLANT; CANCER RADIOTHERAPY; CONTROLLED STUDY; DOG; FEASIBILITY STUDY; GAMMA IRRADIATION; GUINEA PIG; IN VITRO STUDY; IN VIVO STUDY; INSTRUMENT STERILIZATION; MINIMALLY INVASIVE PROCEDURE; MOLECULAR WEIGHT; NONHUMAN; PERINEUM; PROSTATE; PROSTATE CANCER; RADIATION PROTECTION; RECTUM;

ABSORBABLE IMPLANTS; ANIMALS; BALLOON DILATATION; BIOCOMPATIBLE MATERIALS; DOGS; GAMMA RAYS; GUINEA PIGS; MALE; MATERIALS TESTING; METHYLENE CHLORIDE; MOLECULAR WEIGHT; PROSTATIC NEOPLASMS; RADIATION PROTECTION; RADIOTHERAPY; SEPHAROSE; STERILIZATION;

EID: 71649107578     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.31467     Document Type: Article

References (32)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ. Cancer statistic, 2006. CA Cancer J Clin 2006;56:106-130.
2. Webster WS, Small EJ, Rini BI, Kwon ED. Prostate cancer immunology: Biology, therapeutics, and challenges. J Clin Oncol 2005;32:8262-8269.
3. Katz AR. Quality of life for men with prostate cancer. Cancer Nurs 2007;30:302-308. (Pubitemid 47196605)
4. Shishatskaya EI, Volova TG, Puzyr AP, Mogilnaya OA, Efremov SN. Tissue respond to the implantation of biodegradable polyhydroxyalkanoate sutures. J Mater Sci: Mater Med 2004;15:719-728.
5. Albertsson AC, Varma IK. Recent developments in ring opening polymerization of lactones for biomedical applications. Biomacromolecules 2003;4:1466-1486.
6. Semitsch M, Willert H. Clinical wear behavior of ultra high molecular weight polyethylene cups paired with metal and ceramic balls in comparison to metal on metal pairings of hip joint replacements. Proc Inst Mech Eng [H] 1997;211:73-88.
7. Price JS, Tencer AF, Arm DM, Bohach GA. Controlled release of antibiotics from coated orthopedic implants. J Biomed Mater Res 1996;30:281-286. (Pubitemid 26071916)
8. Schmidmaier G, Lucke M, Schwabe P, Raschke M, Haas NP, Wildemann B. Collective review: bioactive implants coated with poly(D,L-lactide) and growth factors IGF-I. TGF-β1, or BMP-2 for stimulation of fracture healing. J Long Term Eff Med Implants 2006;16:61-69.
9. Sumanas WJ, Elliot LC. Novel thromboresistant materials. J Vasc Surg 2007;45:104A-115A.
10. Rajeev AJ. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. Biomaterials 2000;21:2475-2490.
11. Duailibi MT, Duailibi SE, Young CS, Bartlett JD, Vacanti JP, Yelick PC. Bioengineered teeth from cultured rat tooth bud cells. J Dent Res 2004;83:517.
12. Isobe M, Yamazaki Y, Oida S, Ishihara K, Nakabayashi N, Amagasa T. Bone morphogenetic protein encapsulated with a biodegradable and biocompatible polymer. J Biomed Mater Res 1996;32:433-438. (Pubitemid 26356995)
13. Zong X, Li S, Chen E, Garlick B, Kim KS, Fang D, Chiu J, Zimmerman T, Brathwaite C, Hsiao BS, Chu B. Prevention of post surgery-induced abdominal adhesions by electro spun bioabsorable nanofibrious poly(lactide-co-glycolide)- based membranes. Ann Surg 2004;250:910-915.
14. Klopp LS, Simon BJ, Bush JM, Enns RM, Turner AS. Comparison of a caprolactone/lactide film (mesofol) to two polylactide film products as a barrier to postoperative peridural adhesion in an ovine dorsal laminectomy model. Spine 2008;33:1518-1526.
15. Lieshout MV, Peters G, Rutten M, Baaijens F. A knitted, fibrin-covered polycaprolactone scaffold for tissue engineering of the aortic valve. Tissue Eng 2006;12:481-487. (Pubitemid 43673453)
16. Levy Y, Zilberman M. Novel bioresorbabale composite fiber structures loaded with proteins for tissue regeneration applications: Microstructure and protein release. J Biomed Mater Res A 2006;79:779-787. (Pubitemid 44915899)
17. Ratner BD, Hoffman AS, Schoen FJ, Lemones JE, editors. Biomaterials Science, an Introduction to Materials in Medicine. Academic Press; 1996. pp 69-72, 346-356.
18. Commander S, Heleen MM, Beusekom V, Vander WJG. Polymers, drug release, and drug-eluting stents. J Interv Cardiol 2006;19:500-506.
19. Amass W, Amass A, Tighe B. A review of biodegradable polymers: Uses, current developments in the synthesis and characterization of biodegradable polyesters, blends of biodegradable polymers and recent advances in biodegradation studies. Polym Int 1998;47:89-144. (Pubitemid 29126333)
20. Pychaa A, Klinglera CH, Haitela A, Heinz-Peerb G. Implantable microballoons: An attractive alternative in the management of intrinsic sphincter deficiency. Eur Urol 1998;33:469-475.
21. Athanasiou KA, Niederauer GG, Agrawal CM. Sterilization, toxicity, biocompatibility, and clinical applications of polylactic acid/polyglycolic acid copolymers. Biomaterials 1996;17: 93-102.
22. Mazzoli RA, Raymond WR, Ainbinder DJ, Hansen EA. Use of self-expanding, hydrophilic osmotic expanders (hydrogel) in the reconstruction of congenital clinical anophthalmos. Oculoplast Orbital Surg 2004;15:426-431.
23. Mathus-Vliegen EMH, Tytgat GNJ. Intragastric balloon for treatment-resistant obesity: Safety, tolerance, and efficacy of 1-year balloon treatment followed by a 1-year balloon-free follow-up. Gastrointest Endosc 2005;61:19-27.
24. Kfir E, Kfir V, Eliav E, Kaluski E. Minimally invasive antral membrane balloon elevation: Report of 36 procedures. J Periodontol 2007;78:2032-2035.
25. Middleton JC, Tipton AJ. Synthetic biodegradable polymers as orthopedic devices. Biomaterials 2000;23:2235-2346.
26. Higgs ZC, Macafee DA, Braithwaite BD, Maxwell-Armstrong CA. The Seldinger technique: 50 years on. Lancet 2005;366: 1407-1409.
27. Dubois M, Gilles KA, Hamilton JR, Rebers PA, Smith F. Colorimetric method for determination of sugars and related substances. Anal Chem 1965;28:350-356.
28. Choa HH, Hana DK, Matsumuraa K, Tsutsumia S, Hyon SH. The behavior of vascular smooth muscle cells and platelets onto epigallocatechin gallate-releasing poly(L-lactide-co-ε-caprolactone) as stent-coating materials. Biomaterials 2007;29: 884-893.
29. Jeong SI, Kim SH, Kim YH, Jung Y, Kwon JH, Kim BS, Lee YM. Manufacture of elastic biodegradable PLCL scaffolds for mechano-active vascular tissue engineering. J Biomater Sci Polym Ed 2004;15:645-660. (Pubitemid 38842405)
30. Chris A. Burks. Kirk Bundy, Parwis Fotuhi, Eckhard Alt. Characterization of 75:25 poly(L-lactide-co-ε-caprolactone) thin films for the endoluminal delivery of adipose-derived stem cells to abdominal aortic aneurysms. Tissue Eng 2006; 12:2591-2600.
31. Ben-Yosef R, Paz A, Levy Y, Alani S, Muncher Y, Shohat S, Domb A, Corn B. A novel device for protecting rectum during prostate cancer irridation: In vivo data on a large mammal model. J Urol 2009;191:1401-1406.
32. Breuls R, Helder MN. Eur Patent EP-1,908,820-A1 (Application No. 06076845.4); 2006.